| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Embryonic Stem Cells | 10 | 2014 | 57 | 2.200 |
Why?
|
| Induced Pluripotent Stem Cells | 6 | 2023 | 36 | 1.780 |
Why?
|
| Pluripotent Stem Cells | 8 | 2023 | 31 | 1.720 |
Why?
|
| Stem Cell Transplantation | 2 | 2016 | 31 | 1.040 |
Why?
|
| Fertilization | 10 | 2019 | 37 | 1.010 |
Why?
|
| Cell Culture Techniques | 6 | 2018 | 136 | 0.980 |
Why?
|
| Models, Animal | 3 | 2016 | 131 | 0.740 |
Why?
|
| Papio anubis | 1 | 2018 | 5 | 0.650 |
Why?
|
| Centrosome | 6 | 1999 | 28 | 0.630 |
Why?
|
| Stem Cells | 4 | 2016 | 132 | 0.620 |
Why?
|
| Animals | 47 | 2023 | 14307 | 0.590 |
Why?
|
| Cell Differentiation | 10 | 2023 | 562 | 0.580 |
Why?
|
| Spermatozoa | 9 | 2019 | 191 | 0.510 |
Why?
|
| Parkinson Disease | 1 | 2016 | 167 | 0.510 |
Why?
|
| Microtubules | 12 | 2019 | 113 | 0.510 |
Why?
|
| Primates | 3 | 2019 | 36 | 0.510 |
Why?
|
| Macaca mulatta | 7 | 2019 | 122 | 0.500 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2014 | 32 | 0.480 |
Why?
|
| Oocytes | 13 | 2019 | 143 | 0.470 |
Why?
|
| Zygote | 8 | 2019 | 39 | 0.460 |
Why?
|
| Fertilization in Vitro | 10 | 2019 | 56 | 0.460 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2018 | 283 | 0.420 |
Why?
|
| G2 Phase | 2 | 2009 | 25 | 0.410 |
Why?
|
| Cells, Cultured | 9 | 2018 | 1442 | 0.400 |
Why?
|
| Mitochondria | 4 | 2009 | 454 | 0.390 |
Why?
|
| Mast Cells | 5 | 2016 | 77 | 0.380 |
Why?
|
| Nuclear Transfer Techniques | 4 | 2004 | 15 | 0.380 |
Why?
|
| DNA-Binding Proteins | 4 | 2009 | 522 | 0.380 |
Why?
|
| Francisella tularensis | 3 | 2016 | 115 | 0.360 |
Why?
|
| Electron Transport Complex III | 1 | 2009 | 12 | 0.360 |
Why?
|
| G1 Phase | 1 | 2009 | 32 | 0.360 |
Why?
|
| Cloning, Organism | 3 | 2004 | 22 | 0.350 |
Why?
|
| Enzyme Inhibitors | 5 | 2010 | 396 | 0.350 |
Why?
|
| Mice | 18 | 2023 | 5668 | 0.340 |
Why?
|
| Cell Cycle Proteins | 2 | 2009 | 220 | 0.340 |
Why?
|
| Tularemia | 4 | 2018 | 114 | 0.330 |
Why?
|
| Immunohistochemistry | 8 | 2016 | 859 | 0.330 |
Why?
|
| Cytoskeleton | 5 | 2004 | 98 | 0.320 |
Why?
|
| Antineoplastic Agents | 8 | 2001 | 756 | 0.320 |
Why?
|
| Polymerase Chain Reaction | 3 | 2016 | 430 | 0.320 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 184 | 0.310 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2004 | 121 | 0.310 |
Why?
|
| Pedigree | 1 | 2007 | 64 | 0.310 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2020 | 54 | 0.290 |
Why?
|
| Gene Expression | 4 | 2014 | 639 | 0.290 |
Why?
|
| Papio | 3 | 2016 | 21 | 0.290 |
Why?
|
| Organometallic Compounds | 3 | 2001 | 68 | 0.290 |
Why?
|
| Blastocyst | 3 | 2008 | 48 | 0.280 |
Why?
|
| Mice, Inbred NOD | 3 | 2018 | 43 | 0.260 |
Why?
|
| Cell Cycle | 5 | 2011 | 309 | 0.250 |
Why?
|
| Mammals | 2 | 1995 | 96 | 0.250 |
Why?
|
| Enzyme Precursors | 1 | 2004 | 10 | 0.250 |
Why?
|
| Drug Design | 3 | 2004 | 154 | 0.240 |
Why?
|
| Microscopy, Confocal | 8 | 2016 | 210 | 0.240 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 600 | 0.240 |
Why?
|
| Octamer Transcription Factor-3 | 3 | 2014 | 18 | 0.230 |
Why?
|
| Macrophages | 2 | 2018 | 431 | 0.230 |
Why?
|
| Humans | 38 | 2023 | 34853 | 0.230 |
Why?
|
| Cell Nucleus | 6 | 2019 | 351 | 0.220 |
Why?
|
| Karyotyping | 3 | 2013 | 46 | 0.220 |
Why?
|
| Base Sequence | 6 | 2013 | 932 | 0.210 |
Why?
|
| Infertility, Male | 3 | 1997 | 44 | 0.210 |
Why?
|
| Parthenogenesis | 3 | 2019 | 9 | 0.200 |
Why?
|
| Vanadium Compounds | 1 | 2001 | 1 | 0.200 |
Why?
|
| Signal Transduction | 5 | 2018 | 1802 | 0.200 |
Why?
|
| Bone Regeneration | 1 | 2020 | 4 | 0.200 |
Why?
|
| Male | 25 | 2019 | 18870 | 0.190 |
Why?
|
| Cell Line | 6 | 2009 | 1289 | 0.190 |
Why?
|
| DNA Primers | 2 | 2013 | 269 | 0.190 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2020 | 68 | 0.190 |
Why?
|
| Tubulin | 4 | 2001 | 80 | 0.180 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2019 | 67 | 0.180 |
Why?
|
| Cattle | 8 | 2004 | 472 | 0.170 |
Why?
|
| Fibroblasts | 4 | 2010 | 252 | 0.170 |
Why?
|
| Embryo, Mammalian | 4 | 2011 | 152 | 0.160 |
Why?
|
| Phagosomes | 1 | 2018 | 30 | 0.160 |
Why?
|
| Osteogenesis | 2 | 2020 | 31 | 0.160 |
Why?
|
| Receptors, IgE | 2 | 2016 | 22 | 0.160 |
Why?
|
| Bacterial Infections | 1 | 2018 | 44 | 0.160 |
Why?
|
| Female | 25 | 2019 | 19873 | 0.160 |
Why?
|
| Insulin-Secreting Cells | 2 | 2009 | 27 | 0.160 |
Why?
|
| Fathers | 1 | 1997 | 26 | 0.150 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2016 | 10 | 0.150 |
Why?
|
| Caspase 1 | 1 | 2016 | 15 | 0.150 |
Why?
|
| Quinazolines | 3 | 2002 | 31 | 0.140 |
Why?
|
| Intestines | 1 | 2016 | 63 | 0.140 |
Why?
|
| Vaccines, Attenuated | 1 | 2016 | 72 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 10 | 2001 | 480 | 0.140 |
Why?
|
| Protein Isoforms | 3 | 2014 | 121 | 0.140 |
Why?
|
| Furans | 3 | 2000 | 34 | 0.140 |
Why?
|
| Transcription Factors | 4 | 2005 | 653 | 0.140 |
Why?
|
| Patch-Clamp Techniques | 1 | 2016 | 214 | 0.140 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2001 | 37 | 0.140 |
Why?
|
| Bacterial Vaccines | 1 | 2016 | 122 | 0.130 |
Why?
|
| Dopamine | 1 | 2016 | 232 | 0.130 |
Why?
|
| Rodentia | 1 | 1995 | 41 | 0.130 |
Why?
|
| Fertility | 1 | 1995 | 59 | 0.130 |
Why?
|
| Action Potentials | 1 | 2016 | 219 | 0.130 |
Why?
|
| Reproduction | 1 | 1995 | 63 | 0.130 |
Why?
|
| Sperm Head | 1 | 1994 | 10 | 0.120 |
Why?
|
| Genetic Variation | 1 | 1996 | 328 | 0.120 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 391 | 0.120 |
Why?
|
| Cell Division | 3 | 2006 | 296 | 0.120 |
Why?
|
| Myocytes, Cardiac | 2 | 2006 | 165 | 0.120 |
Why?
|
| Embryo Transfer | 4 | 2011 | 34 | 0.110 |
Why?
|
| Osteoblasts | 1 | 2012 | 33 | 0.110 |
Why?
|
| Electric Stimulation | 1 | 2012 | 177 | 0.110 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1149 | 0.110 |
Why?
|
| Microinjections | 3 | 2004 | 55 | 0.110 |
Why?
|
| Mice, SCID | 3 | 2009 | 143 | 0.110 |
Why?
|
| Tissue Engineering | 1 | 2012 | 59 | 0.110 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 25 | 0.110 |
Why?
|
| Meiosis | 3 | 2004 | 60 | 0.110 |
Why?
|
| Apoptosis | 3 | 2014 | 1317 | 0.110 |
Why?
|
| RNA, Messenger | 3 | 2014 | 1152 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2007 | 605 | 0.100 |
Why?
|
| Homeodomain Proteins | 2 | 2009 | 128 | 0.100 |
Why?
|
| Chimera | 1 | 2011 | 15 | 0.100 |
Why?
|
| Haplorhini | 1 | 2011 | 21 | 0.100 |
Why?
|
| Pyrans | 2 | 2001 | 9 | 0.100 |
Why?
|
| Spiro Compounds | 2 | 2001 | 10 | 0.100 |
Why?
|
| Teratoma | 2 | 2009 | 8 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 2 | 2009 | 200 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2009 | 286 | 0.100 |
Why?
|
| Genomic Instability | 1 | 2011 | 34 | 0.100 |
Why?
|
| Farnesyltranstransferase | 1 | 2010 | 4 | 0.100 |
Why?
|
| Progeria | 1 | 2010 | 9 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2004 | 184 | 0.090 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2010 | 34 | 0.090 |
Why?
|
| Models, Biological | 2 | 2009 | 642 | 0.090 |
Why?
|
| Phenotype | 2 | 2007 | 650 | 0.090 |
Why?
|
| Adaptation, Physiological | 1 | 2011 | 106 | 0.090 |
Why?
|
| Insulin | 2 | 2009 | 224 | 0.090 |
Why?
|
| Antimycin A | 1 | 2009 | 5 | 0.090 |
Why?
|
| Radiation, Ionizing | 1 | 2009 | 13 | 0.090 |
Why?
|
| Gamma Rays | 1 | 2009 | 25 | 0.090 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2009 | 37 | 0.090 |
Why?
|
| Sperm-Ovum Interactions | 4 | 1996 | 13 | 0.090 |
Why?
|
| Chromosomes, Human | 1 | 2009 | 31 | 0.090 |
Why?
|
| DNA Repair | 1 | 2010 | 181 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2009 | 878 | 0.080 |
Why?
|
| Genomic Imprinting | 1 | 2008 | 35 | 0.080 |
Why?
|
| DNA, Mitochondrial | 2 | 2006 | 165 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 5 | 2006 | 240 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 87 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2009 | 834 | 0.070 |
Why?
|
| Cell Separation | 1 | 2007 | 91 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 416 | 0.070 |
Why?
|
| Immunity, Innate | 2 | 2018 | 135 | 0.070 |
Why?
|
| Breast Neoplasms | 3 | 2004 | 1426 | 0.070 |
Why?
|
| C-Peptide | 1 | 2005 | 6 | 0.070 |
Why?
|
| Pregnancy | 3 | 2011 | 1503 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 1530 | 0.070 |
Why?
|
| Flow Cytometry | 3 | 2002 | 392 | 0.070 |
Why?
|
| Interleukin-4 | 2 | 2018 | 69 | 0.070 |
Why?
|
| Chromatin | 2 | 1996 | 164 | 0.070 |
Why?
|
| Macaca | 1 | 2004 | 38 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 64 | 0.060 |
Why?
|
| Embryonic Development | 1 | 2004 | 73 | 0.060 |
Why?
|
| Cytoplasm | 3 | 2004 | 135 | 0.060 |
Why?
|
| Mitochondria, Heart | 1 | 2005 | 66 | 0.060 |
Why?
|
| Genome | 1 | 2004 | 117 | 0.060 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2001 | 81 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 1999 | 781 | 0.060 |
Why?
|
| Protein Transport | 2 | 2016 | 286 | 0.060 |
Why?
|
| Aneuploidy | 1 | 2003 | 20 | 0.060 |
Why?
|
| Callithrix | 1 | 2023 | 9 | 0.060 |
Why?
|
| Electroporation | 1 | 2003 | 18 | 0.060 |
Why?
|
| Zebrafish | 2 | 2001 | 118 | 0.060 |
Why?
|
| DNA | 4 | 2000 | 549 | 0.050 |
Why?
|
| Thrombopoietin | 1 | 2002 | 4 | 0.050 |
Why?
|
| P-Selectin | 1 | 2002 | 5 | 0.050 |
Why?
|
| Germ Cells | 1 | 2023 | 70 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 3 | 2016 | 649 | 0.050 |
Why?
|
| Transfection | 2 | 2018 | 496 | 0.050 |
Why?
|
| Leukocytes | 1 | 2002 | 68 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2001 | 13 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2002 | 106 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2002 | 74 | 0.050 |
Why?
|
| Nervous System Neoplasms | 1 | 2001 | 2 | 0.050 |
Why?
|
| Vanadium | 1 | 2001 | 6 | 0.050 |
Why?
|
| Leukotriene C4 | 1 | 2000 | 5 | 0.050 |
Why?
|
| Phosphoproteins | 2 | 1999 | 154 | 0.050 |
Why?
|
| Embryo, Nonmammalian | 1 | 2001 | 57 | 0.050 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 12 | 0.050 |
Why?
|
| Calcium Phosphates | 1 | 2020 | 11 | 0.050 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2001 | 56 | 0.050 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2000 | 30 | 0.050 |
Why?
|
| Calcification, Physiologic | 1 | 2020 | 13 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2001 | 49 | 0.050 |
Why?
|
| Fatty Alcohols | 1 | 2000 | 7 | 0.050 |
Why?
|
| Materials Testing | 1 | 2020 | 71 | 0.050 |
Why?
|
| Femur | 1 | 2020 | 35 | 0.050 |
Why?
|
| Vanadates | 1 | 2000 | 7 | 0.050 |
Why?
|
| Disulfides | 2 | 1999 | 77 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2020 | 123 | 0.050 |
Why?
|
| Sperm Tail | 2 | 1996 | 3 | 0.050 |
Why?
|
| Mitosis | 1 | 2001 | 97 | 0.050 |
Why?
|
| Extrachromosomal Inheritance | 1 | 1999 | 2 | 0.050 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1999 | 8 | 0.050 |
Why?
|
| Macaca fascicularis | 1 | 2019 | 61 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 1999 | 18 | 0.050 |
Why?
|
| Collagen | 1 | 2020 | 162 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 1999 | 82 | 0.040 |
Why?
|
| Aniline Compounds | 1 | 1998 | 21 | 0.040 |
Why?
|
| Immunoglobulin E | 1 | 1999 | 54 | 0.040 |
Why?
|
| Arabidopsis Proteins | 1 | 1999 | 38 | 0.040 |
Why?
|
| Nitriles | 1 | 1998 | 66 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 249 | 0.040 |
Why?
|
| Mycobacterium bovis | 1 | 2018 | 14 | 0.040 |
Why?
|
| Immune Evasion | 1 | 2018 | 16 | 0.040 |
Why?
|
| Mycobacterium Infections | 1 | 2018 | 16 | 0.040 |
Why?
|
| Endosomes | 1 | 2018 | 34 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 2005 | 1490 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 1999 | 181 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2018 | 53 | 0.040 |
Why?
|
| Sulfhydryl Reagents | 1 | 1997 | 6 | 0.040 |
Why?
|
| Dithiothreitol | 1 | 1997 | 18 | 0.040 |
Why?
|
| Cell Surface Extensions | 1 | 2016 | 7 | 0.040 |
Why?
|
| Micromanipulation | 1 | 1996 | 11 | 0.040 |
Why?
|
| Morula | 1 | 1996 | 2 | 0.040 |
Why?
|
| Estrus | 1 | 1996 | 14 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 2006 | 550 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2016 | 96 | 0.040 |
Why?
|
| Interleukin-17 | 1 | 2016 | 54 | 0.030 |
Why?
|
| Rats | 2 | 2020 | 3261 | 0.030 |
Why?
|
| Immunity | 1 | 2016 | 51 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 1534 | 0.030 |
Why?
|
| Cell Communication | 1 | 2016 | 93 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2016 | 87 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2018 | 287 | 0.030 |
Why?
|
| Spleen | 1 | 2016 | 192 | 0.030 |
Why?
|
| Ikaros Transcription Factor | 3 | 1999 | 8 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2016 | 235 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2005 | 1124 | 0.030 |
Why?
|
| Marsupialia | 1 | 1994 | 4 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1996 | 528 | 0.030 |
Why?
|
| Paclitaxel | 2 | 2004 | 48 | 0.030 |
Why?
|
| Blastomeres | 2 | 2009 | 9 | 0.030 |
Why?
|
| Actins | 1 | 1995 | 142 | 0.030 |
Why?
|
| Chromosomes | 2 | 2004 | 35 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2004 | 107 | 0.030 |
Why?
|
| Electromagnetic Fields | 1 | 2012 | 8 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2012 | 32 | 0.030 |
Why?
|
| Cell Survival | 3 | 2001 | 818 | 0.030 |
Why?
|
| Benzimidazoles | 2 | 2006 | 36 | 0.030 |
Why?
|
| Models, Molecular | 3 | 2000 | 751 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2004 | 287 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 58 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2011 | 38 | 0.030 |
Why?
|
| Fluorescent Dyes | 2 | 2006 | 173 | 0.030 |
Why?
|
| Cell Death | 1 | 2012 | 260 | 0.020 |
Why?
|
| Embryo Implantation | 1 | 2011 | 29 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2006 | 455 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 72 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2009 | 7 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2009 | 7 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2009 | 14 | 0.020 |
Why?
|
| Subcellular Fractions | 2 | 1999 | 72 | 0.020 |
Why?
|
| Zinc Fingers | 2 | 1999 | 25 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2009 | 10 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2000 | 107 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2009 | 11 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2009 | 20 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2012 | 897 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 132 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2009 | 197 | 0.020 |
Why?
|
| Telomerase | 1 | 2009 | 40 | 0.020 |
Why?
|
| Protein Conformation | 2 | 2000 | 350 | 0.020 |
Why?
|
| Child | 3 | 2001 | 2875 | 0.020 |
Why?
|
| Calcium | 2 | 2002 | 445 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 170 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 984 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1056 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1996 | 186 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2006 | 14 | 0.020 |
Why?
|
| Secretory Vesicles | 1 | 2005 | 19 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 78 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2006 | 74 | 0.020 |
Why?
|
| Infant | 2 | 1999 | 1014 | 0.020 |
Why?
|
| Child, Preschool | 2 | 1999 | 1318 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2006 | 213 | 0.020 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2004 | 2 | 0.020 |
Why?
|
| Genome, Human | 1 | 2006 | 112 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2004 | 9 | 0.020 |
Why?
|
| Molecular Motor Proteins | 1 | 2004 | 8 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2004 | 54 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2008 | 301 | 0.020 |
Why?
|
| Mutation | 2 | 1999 | 1023 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 70 | 0.020 |
Why?
|
| RNA | 1 | 2006 | 234 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 180 | 0.010 |
Why?
|
| Peritonitis | 1 | 2002 | 8 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2002 | 19 | 0.010 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2002 | 1 | 0.010 |
Why?
|
| Platelet Factor 4 | 1 | 2002 | 2 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 2002 | 14 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 2002 | 10 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2002 | 64 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2002 | 109 | 0.010 |
Why?
|
| Escherichia coli Infections | 1 | 2002 | 39 | 0.010 |
Why?
|
| Cytogenetic Analysis | 1 | 2001 | 5 | 0.010 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2001 | 5 | 0.010 |
Why?
|
| Neoplasm, Residual | 1 | 2001 | 13 | 0.010 |
Why?
|
| Remission Induction | 1 | 2001 | 18 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2001 | 34 | 0.010 |
Why?
|
| Hydroxybutyrates | 1 | 2001 | 2 | 0.010 |
Why?
|
| Pentanones | 1 | 2001 | 4 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2001 | 71 | 0.010 |
Why?
|
| Calcimycin | 1 | 2000 | 11 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2001 | 114 | 0.010 |
Why?
|
| Eosinophils | 1 | 2000 | 19 | 0.010 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2000 | 10 | 0.010 |
Why?
|
| Janus Kinase 3 | 1 | 2000 | 33 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 2000 | 32 | 0.010 |
Why?
|
| Drug Stability | 1 | 2001 | 110 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2001 | 70 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2001 | 237 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 485 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 2000 | 32 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 126 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1999 | 84 | 0.010 |
Why?
|
| Cell Extracts | 1 | 1999 | 16 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1999 | 12 | 0.010 |
Why?
|
| Binding Sites | 1 | 2001 | 597 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 1999 | 73 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1999 | 103 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1999 | 89 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2001 | 467 | 0.010 |
Why?
|
| Fatty Acid Desaturases | 1 | 1999 | 4 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2002 | 436 | 0.010 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 1999 | 8 | 0.010 |
Why?
|
| Tumor Stem Cell Assay | 1 | 1998 | 21 | 0.010 |
Why?
|
| Isoxazoles | 1 | 1998 | 11 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1999 | 117 | 0.010 |
Why?
|
| Cell Lineage | 1 | 1999 | 88 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 87 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1999 | 65 | 0.010 |
Why?
|
| Plant Proteins | 1 | 1999 | 93 | 0.010 |
Why?
|
| Sea Urchins | 1 | 1997 | 9 | 0.010 |
Why?
|
| Amphibians | 1 | 1997 | 8 | 0.010 |
Why?
|
| Lysophosphatidylcholines | 1 | 1997 | 19 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 555 | 0.010 |
Why?
|
| Acrosome | 1 | 1996 | 2 | 0.010 |
Why?
|
| Cytochalasin B | 1 | 1996 | 4 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2001 | 1353 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1997 | 138 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1999 | 203 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1999 | 287 | 0.010 |
Why?
|
| Insemination, Artificial | 1 | 1996 | 9 | 0.010 |
Why?
|
| Injections | 1 | 1996 | 35 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1999 | 406 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1999 | 341 | 0.010 |
Why?
|
| Culture Media | 1 | 1996 | 84 | 0.010 |
Why?
|
| Parents | 1 | 1999 | 288 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1997 | 407 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1999 | 901 | 0.010 |
Why?
|
| Centrioles | 1 | 1994 | 2 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1996 | 360 | 0.010 |
Why?
|
| Adult | 2 | 1999 | 11034 | 0.010 |
Why?
|
| Risk Factors | 1 | 2001 | 3414 | 0.010 |
Why?
|
| Neoplasms | 1 | 2000 | 1033 | 0.010 |
Why?
|
| Adolescent | 1 | 1999 | 5035 | 0.010 |
Why?
|